CFM
Catalyst Funds Management Portfolio holdings
AUM
$362M
This Quarter Return
+18.75%
1 Year Return
+42.71%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$362M
AUM Growth
+$362M
(-5.3%)
Cap. Flow
-$55M
Cap. Flow
% of AUM
-15.19%
Top 10 Holdings %
Top 10 Hldgs %
19.16%
Holding
737
New
289
Increased
45
Reduced
94
Closed
308
Top Buys
| 1 |
VanEck Gold Miners ETF
GDX
|
$10.3M |
| 2 |
Amphenol
APH
|
$7.72M |
| 3 |
Applovin
APP
|
$6.08M |
| 4 |
Insmed
INSM
|
$4.75M |
| 5 |
CRH
CRH
|
$3.87M |
Top Sells
| 1 |
Rio Tinto
RIO
|
$11.5M |
| 2 |
NVIDIA
NVDA
|
$8.98M |
| 3 |
Pfizer
PFE
|
$7.17M |
| 4 |
iShares Bitcoin Trust
IBIT
|
$7.02M |
| 5 |
GE Vernova
GEV
|
$5.77M |
Sector Composition
| 1 | Technology | 19.52% |
| 2 | Financials | 14.68% |
| 3 | Industrials | 12.22% |
| 4 | Materials | 11.75% |
| 5 | Healthcare | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
S&P Global
SPGI
$165B
| – | – |
-960
| Closed | -$488K |
|
602
Sterling Infrastructure
STRL
$8.42B
| – | – |
-4,000
| Closed | -$453K |
|
603
Sun Communities
SUI
$15.6B
| – | – |
-9,600
| Closed | -$1.23M |
|
604
Teradata
TDC
$1.96B
| – | – |
-15,200
| Closed | -$342K |
|
605
Truist Financial
TFC
$59.9B
| – | – |
-9,000
| Closed | -$370K |
|
606
Teleflex
TFX
$5.61B
| – | – |
-10,640
| Closed | -$1.47M |
|
607
TJX Companies
TJX
$155B
| – | – |
-2,280
| Closed | -$278K |
|
608
Alpha Teknova
TKNO
$226M
| – | – |
-18,831
| Closed | -$97.7K |
|
609
AbbVie
ABBV
$374B
| – | – |
-6,300
| Closed | -$1.32M |
|
610
Archer Aviation
ACHR
$5.55B
| – | – |
-49,200
| Closed | -$350K |
|
611
Aclaris Therapeutics
ACRS
$216M
| – | – |
-16,698
| Closed | -$25.5K |
|
612
AES
AES
$9.55B
| – | – |
-207,600
| Closed | -$2.58M |
|
613
Atlas Energy Solutions
AESI
$1.4B
| – | – |
-10,800
| Closed | -$193K |
|
614
Agios Pharmaceuticals
AGIO
$2.28B
| – | – |
-11,200
| Closed | -$328K |
|
615
Alaska Air
ALK
$7.22B
| – | – |
-12,600
| Closed | -$620K |
|
616
Alkami Technology
ALKT
$2.56B
| – | – |
-10,800
| Closed | -$284K |
|
617
Allogene Therapeutics
ALLO
$249M
| – | – |
-14,580
| Closed | -$21.3K |
|
618
Alto Ingredients
ALTO
$87.5M
| – | – |
-17,557
| Closed | -$20K |
|
619
Antero Midstream
AM
$8.46B
| – | – |
-55,200
| Closed | -$994K |
|
620
Applied Materials
AMAT
$126B
| – | – |
-3,000
| Closed | -$435K |
|
621
Ambac
AMBC
$414M
| – | – |
-12,840
| Closed | -$112K |
|
622
Amgen
AMGN
$154B
| – | – |
-1,800
| Closed | -$561K |
|
623
Amylyx Pharmaceuticals
AMLX
$890M
| – | – |
-14,905
| Closed | -$52.8K |
|
624
Abercrombie & Fitch
ANF
$4.38B
| – | – |
-2,640
| Closed | -$202K |
|
625
Annexon
ANNX
$227M
| – | – |
-11,760
| Closed | -$22.7K |
|